[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336599-105":59,"doc-detail-336599-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","current-understanding-of-the-role-of-adenosine-receptors-in-cancer-review","Current Understanding of the Role of Adenosine Receptors in Cancer - Review","","Cancer is a complex set of diseases driven by uncontrolled proliferation and spread of aberrant cells, producing tumors that infiltrate nearby tissues and metastasize. With more than 200 cancer types, each shows distinct features, risk profiles, and treatment routes, yet current options face limitations including late diagnoses, heterogeneity, toxicity, resistance, delivery challenges, and cost. Research advances support earlier detection, expanded therapies, and improved survival. Adenosine receptors (A1, A2A, A2B, A3) can either promote or inhibit tumor progression depending on receptor subtype, cancer context, and tumor microenvironment. Preclinical studies suggest that adenosine receptor ligands may offer anticancer therapeutic potential. Mapping receptor signaling networks is essential for designing targeted strategies that maximize benefit while reducing drawbacks. This review summarizes subtype-specific roles and pathways to clarify how targeting adenosine receptors may improve treatment outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-understanding-of-the-role-of-adenosine-receptors-in-cancer-review/336599/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-understanding-of-the-role-of-adenosine-receptors-in-cancer-review/336599.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is adenosine relevant to cancer biology?","Question",{"text":113,"@type":114},"Adenosine can be released from cells or generated extracellularly by ATP degradation via CD73 and CD39. It can suppress antitumor immune responses and contributes to an immunosuppressive tumor environment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do different adenosine receptor subtypes influence tumor progression?",{"text":118,"@type":114},"Adenosine receptors (A1, A2A, A2B, A3) can either promote or inhibit tumor growth depending on the receptor subtype, the cancer type, and the tumor microenvironment.",{"name":120,"@type":111,"acceptedAnswer":121},"What do studies suggest about targeting adenosine receptor signaling for therapy?",{"text":122,"@type":114},"Research on adenosine receptor ligands shows promising anticancer effects in laboratory and animal models. Understanding the receptor signaling pathways and interactions can support development of targeted therapies that improve outcomes while mitigating drawbacks.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336599,1790688577,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","molecules   \nReview  \nCurrent Understanding of the Role of Adenosine Receptors in Cancer  \nKatharigatta Narayanaswamy Venugopala 1,2, * and Michela Buccioni 3  \nCitation: Venugopala, K.N.; Buccioni, M. Current Understanding of the Role of Adenosine Receptors in Cancer. Molecules 2024, 29, 3501. [https://](https://)[ ](https://)[doi.org/10.3390/molecules29153501](doi.org/10.3390/molecules29153501)  \nReceived: 8 June 2024  \nRevised: 21 July 2024  \nAccepted: 22 July 2024  \nPublished: 26 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia  \n2 Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, Durban 4001, South Africa  \n3 School of Pharmacy, Medicinal Chemistry Unit, ChIP, University of Camerino, Via Madonna delle Carceri, 62032 Camerino, Italy; [michela.buccioni@unicam.it](michela.buccioni@unicam.it)  \n* Correspondence: [kvenugopala@kfu.edu.sa](kvenugopala@kfu.edu.sa); Tel.: +966-135898842  \nAbstract: Cancer, a complex array of diseases, involves the unbridled proliferation and dissemination of aberrant cells in the body, forming tumors that can infiltrate neighboring tissues and metastasize to distant sites. With over 200 types, each cancer has unique attributes, risks, and treatment avenues. Therapeutic options encompass surgery, chemotherapy, radiation therapy, hormone therapy, immunotherapy, targeted therapy, or a blend of these methods. Yet, these treatments face challenges like late-stage diagnoses, tumor diversity, severe side effects, drug resistance, targeted drug delivery hurdles, and cost barriers. Despite these hurdles, advancements in cancer research, encompassing biology, genetics, and treatment, have enhanced early detection methods, treatment options, and survival rates. Adenosine receptors (ARs), including A 1, A2A, A2B, and A3 subtypes, exhibit diverse roles in cancer progression, sometimes promoting or inhibiting tumor growth depending on the receptor subtype, cancer type, and tumor microenvironment. Research on AR ligands has revealed promising anticancer effects in lab studies and animal models, hinting at their potential as cancer therapeutics. Understanding the intricate signaling pathways and interactions of adenosine receptors in cancer is pivotal for crafting targeted therapies that optimize benefits while mitigating drawbacks. This review delves into each adenosine receptor subtype’s distinct roles and signaling pathways in cancer, shedding light on their potential as targets for improving cancer treatment outcomes.  \nKeywords: adenosine receptors; A 1, A2A, A2B, and A3 adenosine receptors; cancer; tumor  \n1. Introduction  \nCancer cells display numerous characteristics such as rapid proliferation, resistance to cell death, evasion of the immune system, sustained growth through limitless replication, formation of new blood vessels (neoangiogenesis), and the ability to spread to distant sites (metastasis) . The continual persistence of malignant cells underscores the insufficiency of the host’s immune defenses in curbing tumor proliferation and metastasis. Malignant cells create an environment that suppresses the immune system, enabling their unrestricted proliferation and development [1–4] . Adenosine, classified as a purine nucleoside, can be either released from cells or generated externally through the degradation of ATP by two specific enzymes located on the cell surface: CD73 and CD39 [5,6] . Adenosine can inhibit several immune cells participating in antitumor activities and facilitate the formation of immun","cbCaifCwcfHUWd0t","https://ap.wps.com/l/cbCaifCwcfHUWd0t","pdf",3866945,31,"English","# Introduction\n## Adenosine and adenosine receptor biology in cancer\n# Adenosine receptors in cancer progression\n## Subtype-specific roles of A1, A2A, A2B, and A3\n## Signaling pathways and tumor microenvironment interactions\n# Anticancer potential of adenosine receptor ligands","[{\"question\":\"Why is adenosine relevant to cancer biology?\",\"answer\":\"Adenosine can be released from cells or generated extracellularly by ATP degradation via CD73 and CD39. It can suppress antitumor immune responses and contributes to an immunosuppressive tumor environment.\"},{\"question\":\"How do different adenosine receptor subtypes influence tumor progression?\",\"answer\":\"Adenosine receptors (A1, A2A, A2B, A3) can either promote or inhibit tumor growth depending on the receptor subtype, the cancer type, and the tumor microenvironment.\"},{\"question\":\"What do studies suggest about targeting adenosine receptor signaling for therapy?\",\"answer\":\"Research on adenosine receptor ligands shows promising anticancer effects in laboratory and animal models. Understanding the receptor signaling pathways and interactions can support development of targeted therapies that improve outcomes while mitigating drawbacks.\"}]","Current Understanding of the Role of Adenosine Receptors in Cancer - Review | PDF",1790015794,78,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e20c24d75ee6bfda436d65bc4b5c31f.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/278897698f07edfec4a0833303536ee0.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a5633b382cb1482abca60168504f6ef.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/667c9fc734c998d716c28ee67d6d9ee2.webp",980,1385]